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Abstract
To replicate in mammalian hosts, bacterial pathogens must acquire iron. The majority of iron is coordinated to the
protoporphyrin ring of heme, which is further bound to hemoglobin. Pathogenic bacteria utilize secreted hemophores to
acquire heme from heme sources such as hemoglobin. Bacillus anthracis, the causative agent of anthrax disease, secretes
two hemophores, IsdX1 and IsdX2, to acquire heme from host hemoglobin and enhance bacterial replication in iron-starved
environments. Both proteins contain NEAr-iron Transporter (NEAT) domains, a conserved protein module that functions in
heme acquisition in Gram-positive pathogens. Here, we report the structure of IsdX1, the first of a Gram-positive
hemophore, with and without bound heme. Overall, IsdX1 forms an immunoglobin-like fold that contains, similar to other
NEAT proteins, a 310-helix near the heme-binding site. Because the mechanistic function of this helix in NEAT proteins is not
yet defined, we focused on the contribution of this region to hemophore and NEAT protein activity, both biochemically and
biologically in cultured cells. Site-directed mutagenesis of amino acids in and adjacent to the helix identified residues
important for heme and hemoglobin association, with some mutations affecting both properties and other mutations
affecting only heme stabilization. IsdX1 with mutations that reduced the ability to associate with hemoglobin and bind
heme failed to restore the growth of a hemophore-deficient strain of B. anthracis on hemoglobin as the sole iron source.
These data indicate that not only is the 310-helix important for NEAT protein biology, but also that the processes of
hemoglobin and heme binding can be both separate as well as coupled, the latter function being necessary for maximal
heme-scavenging activity. These studies enhance our understanding of NEAT domain and hemophore function and set the
stage for structure-based inhibitor design to block NEAT domain interaction with upstream ligands.
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Introduction
An important determinant in the outcome of a bacterial
infection is how well the invading pathogen can acquire host iron.
Hosts with high levels of free iron are more susceptible to infection,
and deletion of iron acquisition systems in a wide range of
bacterial species generally attenuates virulence [1]. The low free
iron concentration in host tissues (10
218–24 M) likely acts as a
barrier to efficient bacterial replication [2]. However, pathogenic
bacteria have evolved at least two distinct uptake systems to attain
iron. One such mechanism is to secrete siderophores, small
molecules that chelate ferric iron with very high affinity [3]. The
iron-bound siderophore binds to the bacterial surface and specific
ferric iron receptors next deliver the iron or iron-siderophore
complex into the cell [4]. The genetic deletion of biosynthetic
systems that make siderophores, or the surface receptors that
recognize siderophores, decreases the virulence of several
pathogens, including the Gram-positive bacteria B. anthracis [5]
and S. aureus [6].
The second system bacteria employ to attain host iron targets
iron-protoporphyrin IX, or heme. Although heme constitutes up
to 80% of the bodily iron reserves, free heme is rare. Most heme is
tightly bound to hemoproteins such as hemoglobin. Hemoglobin’s
important role as an oxygen carrier protein means it is in high
abundance and thus a target for bacterial iron uptake [7–9].
Bacterial proteins that acquire heme from hemoglobin are called
hemophores [10–13]. Hemophores are generally secreted into the
external milieu where they extract heme, via an undefined
mechanism, from heme sources such as hemoglobin [14]. The
heme-bound (holo) hemophore then delivers its bound iron-
porphyrin to a cognate receptor on the bacteria surface, which
leads to heme import into the bacterial cell [15,16]. Heme from
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similar mechanisms involving receptors on the cell wall (Gram
positive) or outer membrane (Gram negative). Heme import by
bacterial pathogens is important for the establishment or
maintenance of infections caused by Bordetella [17], Haemophilus
[18], Brucella [19], Vibrio [20], Streptococcus [21], and Staphylococcus
[22] species. Further, more recent studies suggest heme is a major
determinant in the promotion and severity of bacterial sepsis [23].
Collectively, these studies highlight the important role of heme
acquisition during infection of mammalian hosts and support the
contention that the inhibition of iron uptake systems is a promising
direction for the development of new therapeutics. However,
despite this knowledge, no clinically-used antibiotics have been
made that directly target bacterial iron import. An understanding
of the molecular mechanism by which heme acquisition systems
extract, bind, and transfer heme into bacterial cells would be an
important first step in creating new drugs to treat deadly
infections.
The first discovered hemophore was HasA from the Gram-
negative pathogen S. marcescens [10]. HasA is a small ,15 kDa
protein that seems to passively acquire heme from hemoglobin by
virtue of its high affinity for the iron-porphyrin [24]. HasA delivers
its bound heme to HasR, an outer membrane surface receptor that
delivers the heme into the cell [25]. Whereas the discovery of
HasA set the precedence for the study of hemophores, recent
studies indicate that Gram-positive bacteria also utilize hemo-
phores. B. anthracis, a Gram-positive pathogen that is a potential
weapon for bioterrorism, secretes two hemophores (IsdX1 and
IsdX2), that acquire heme from hemoglobin and promote
bacterial growth in low-iron environments [26–28]. IsdX1
transfers its bound heme to IsdC, a surface protein covalently
attached to the peptidoglycan of the cell wall [29,30]. The heme
acquisition functions of IsdX1, IsdX2, and IsdC are dependent on
the activity of their NEAT (near-iron transporter) domain [26,29].
This approximately 125 amino acid domain is conserved in several
Gram-positive bacteria, and the collective action of several NEATs
on the bacterial surface is hypothesized to lead to transfer of heme
through the cell wall [27,31–33]. The deletion of genes encoding
for NEAT proteins leads to reduction in virulence in both B.
anthracis and S. aureus [34–36]. Further, vaccination of mice with
recombinant proteins containing NEAT domains induces adaptive
immunity to staphylococcal infection. [37–39]. However, the
development of a safe vaccine or a small molecule inhibitor of
NEATs will require a detailed understanding of how NEAT
proteins perform their various heme transport functions, including
a structural appreciation of the residues required for activity. At
the heart of this activity is an understanding of how bacterial
hemophores like IsdX1 mediate the specific extraction of heme
from host hemoglobin, and whether the ability to take up heme is
coupled to the process of heme removal from the globin donor.
The NEAT domain of IsdX1 is the only known NEAT domain to
bind both heme and hemoglobin, as well as acquire heme from
hemoglobin, thus making IsdX1 a useful model protein to study
the relationship of these processes to one another. To better
understand the molecular basis of hemophore activity and provide
mechanistic insights into NEAT protein function, we solved the
structures of heme free and heme bound IsdX1 and used these
structures to understand the functional roles of residues in a small
310-helix in the vicinity of the heme binding site.
Results
The apo and holo structure of IsdX1 highlights residues
involved in hemophore function
To gain an appreciation of the residues in IsdX1 necessary for
the hemophore activity of this protein, we solved the crystal
structure of apo-IsdX1 to 1.8 A ˚ resolution (Table 1). Overall, the
backbone structure of IsdX1 is similar to the solved structures of
NEAT domains from S. aureus, albeit with a unique surface charge
distribution close to the heme binding pocket (Figure S1.) [40–44].
The structure consists of an immunoglobulin-like fold with eight b-
strands arranged in two antiparallel b-sheets of a b-sandwich
(Figure 1A).
The heme-binding pocket is enclosed primarily by a 310-helix
(residues Arg-54 to Tyr-58) on one side of the heme and a long b-
hairpin (b7–b8) on the other. The 310-helix is sometimes referred to
as the ‘‘lip’’ because it seems to protrude over the heme-binding
pocket [42]. The backbone of the 310-helix in IsdX1 is fairly well-
ordered even in the absence of heme. The integrity of the 310-helix
without heme could be due to the hydrogen bonding network
between Ser-52, Ser-53, Arg-54 and Asn-56 and Met-55 from the
helix making van der Waals contacts with residuesin b4, b7,and b8.
The heme bound form of IsdX1 was solved to 2.15 A ˚ by
molecular replacement using the structure of apo-IsdX1 as the
search model. Heme-iron coordination is achieved through Tyr-
136, which is conserved among all heme-binding NEAT domain
proteins (Figure S2, upper panel). The distance between the iron
atom and the tyrosine oxygen ligand is 2.3 A ˚, which is typical for
an Fe-O bond of NEAT domains (Figures 1B and 1C) [40–45].
The coordination bond to iron is stabilized by the conserved
residue Tyr-140, which forms a hydrogen bond with the phenolate
oxygen of Tyr-136. The aromatic ring of Tyr-140 further stabilizes
the pyrrole ring through p-stacking. Both of these residues lie on a
b-hairpin region, a conserved region in bacterial NEAT proteins
that provides a structural platform for the heme [40,42]. The least
solvent exposed heme propionate forms a hydrogen bond with the
hydroxyl group of Ser-53, as well as the backbone nitrogen of Arg-
54. Additionally, the side chain NH1 group of Arg-54 from chain
A also hydrogen bonds to the least solvent exposed heme
propionate, and also to the hydroxyl group of Ser-53 (Figure 2A,
B). However, this hydrogen-bonding network is not observed for
the side chain of Arg-54 from chain B. The heme molecule is
further stabilized by Tyr-58, that weakly p-stacks with the buried
heme pyrrole ring. The other residues lining the heme-binding
pocket are Arg-54, Met-55, Phe-59, Ile-84, Val-127, Ile-129, Ile-
131, Ile-142 and Phe-144, which mainly form an aliphatic
Author Summary
Pathogenic bacteria need to acquire host iron to replicate
during infection. Approximately 80% of mammalian iron is
associated with a small molecule termed heme, most of
which is bound to circulating hemoglobin and involved in
O2 transport in red cells. Bacteria secrete proteins, termed
hemophores, to acquire the heme from hemoglobin, a
process thought to accelerate delivery of the heme to the
bacterial surface for iron import into the cell. The
mechanisms by which hemophores extract host heme
from hemoglobin are not known. Here, we report that the
IsdX1 hemophore from B. anthracis, the causative agent of
anthrax disease, uses a conserved structural feature to link
hemoglobin association with heme binding and extrac-
tion, thereby facilitating bacterial growth in low-iron
environments. Such ‘‘molecular coupling’’ suggests that
specific inhibition of the hemophore-hemoglobin interac-
tion for this class of proteins may serve as a starting point
for new anti-infective therapeutics aimed at short-circuit-
ing iron uptake networks in bacterial pathogens.
Mechanism of a NEAT Hemophore
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heme and its side chains.
The role of the 310-helix in heme binding
The location of the 310-helix in the structures of the NEAT
domains suggests this region is important for NEAT protein
function, including heme binding, hemoglobin association, heme
extraction and NEAT-NEAT heme transfer [41–43,45]. There is
some conservation in this region, as noted by Pilpa et al, with
aromatic residues common in the equivalent positions of amino
acids 54 and 58 for IsdX1 [46]. Interestingly, a serine residue (Ser-
53 in IsdX1), which is immediately adjacent to the first residue of
the helix (Arg-54), is well conserved in these NEATs, including
every NEAT domain from B. anthracis (Figure 3, bold) [47]. To
determine the role of this and adjacent residues in the ability of
IsdX1 to bind heme, each amino acid in 52-SSRM-55 was
changed to alanine and mutant proteins purified from E. coli.
Whereas wild-type IsdX1 co-purified with a significant amount of
endogenous heme from E. coli, IsdX1(SSRMRAAAA) bound
approximately 10-fold less heme after purification (Figure 4A,
quantitated in 4C). Removal of the bound heme by organic
extraction (Figure 4B) and quantitation of the Soret band intensity
after titration of the apo protein with hemin confirmed the heme-
binding defect of the mutant protein (Figure 4D).
To determine the residues responsible for this defect, single
substitution changes in 52-SSRM-55 were generated and each
purified mutantassessed forheme bindingactivity.Asdemonstrated
in Figure 4C and D, mutation of Ser-52, Ser-53, or Met-55
decreased the ability of each of these mutant proteins to either co-
purify with heme (Figure 4C) or bind exogenously added hemin
(Figure 4D). The raw spectra for these mutants are illustrated in
Figure S3. These effects are not due to gross disruption of IsdX1
secondary structure since the mutant proteins retained a similar
overall b-sheet content as the wild-type protein when assessed by
far-UV circular dichroism (Figure S4). Further, the heme binding
site seems to be somewhat intolerant of even small structural
Table 1. Crystallography statistics.
Data Collection, Phasing, and Refinement Statistics
Apo SeMet Holo
Data collection/parameters
Space group P1 P1 P43
Wavelength (A ˚) 0.97929 0.97940 1.0
Cell dimensions
a, b, c (A ˚) 36.6, 43.7, 47.4 37.0, 43.9, 47.7 64.98664.98674.2
a, b, c (u) 99.24, 96.53, 107.35 99.14, 97.44, 106.37
Resolution (A ˚) 46.1-1.80 34.5-2.11 50.0-2.15
Completeness (%)
a 97.2 (94.4) 97.0 (96.3) 99.1 (100.0)
Unique reflections 24540 (2336) 24211 (250118) 16738 (251543)
Rmerge (%)
b 4.5 (35.9) 7.4 (55.1) 4.4 (33.1)
I/s
a 18.1 (1.7) 10.9 (2.3) 43.79 (7.23)
Redundancy
a 2.0 (1.9) 3.9 (3.6) 15.0 (15.1)
SAD Phasing
Resolution (A ˚) 34.5-2.11
Selenium sites (#)2
Figure of merit (before/after density modification) 0.32/0.60
Refinement
Resolution (A ˚) 25.57-1.80 32.49-2.15
Rwork/Rfree
c (%) 20.9/23.4 19.6/23.4
# of protein atoms 1907 1948
# of water molecules 168 87
hemes/monomer 0 1
Rmsd bond lengths (A ˚) 0.002 0.008
Rmsd bond angles (u) 0.566 1.192
PDB ID 3SZ6 3SIK
Ramachandran plot statistics (%)
Preferred regions 210 (95.0) 238 (98.8)
Allowed regions 11 (5.0) 3 (1.2)
Outliers 0 (0) 0 (0)
aValues for the highest resolution shell are shown in parentheses.
bRmerge=S|Ihkl2,Ihkl.|/SIhkl, where I is the observed intensity for reflection hkl, and ,I. is the mean intensity.
cRwork=S||Fo(hkl)|2|Fc(hkl)||/S|Fo(hkl)|; Rfree is calculated in the same way with 5–10% of reflections excluded from refinement.
doi:10.1371/journal.ppat.1002559.t001
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PLoS Pathogens | www.plospathogens.org 3 March 2012 | Volume 8 | Issue 3 | e1002559Figure 1. Apo and holo IsdX1 crystal structures. (A) Ribbon representation of apo-IsdX1 where b-strands and helices are colored pink and cyan,
respectively. Important heme-binding residues are represented in stick model with carbon, sulfur, nitrogen, and oxygen atoms colored white, yellow,
blue and red, respectively. (B) Cartoon representation of holo-IsdX1 where b-strands and helices are colored gold and blue. Heme (purple) is depicted
in stick model with carbon (purple), nitrogen (blue), oxygen (red) and Fe (orange sphere). (C) Heme-binding pocket with Fo2Fc omit map contoured
at 3.0 s (dark blue mesh). Hydrogen bonds are indicated by black dashed lines.
doi:10.1371/journal.ppat.1002559.g001
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only in the length of the side chain (extra methyl group), also
abolished the interaction with heme (Figure 4 C,D). Interestingly,
mutation of Arg-54 led to a purified IsdX1 preparation with a Soret
band approximately three times greater than wild-type protein
(Figure 4C). The high heme content in this sample was confirmed
using the pyridine hemochrome method, which demonstrated the
molar amounts of heme, on average, were 75–90% the molar
concentration of protein, suggesting binding was stoichiometric for
this preparation (data not shown). However, upon removal of the
heme and incubation of R54A with hemin, very little heme bound
the protein, despite a far-UV spectrum indistinguishable from wild-
type protein (Figure 4D, Figure S4). In the structure of apo and
holo-IsdX1, the side chain of Arg-54 shifts 2.5–2.8 A ˚ to
accommodate the heme (Figure 2B). This suggests placement of a
less bulky residue (alanine) in place of Arg-54 may allow heme
access to the heme-binding site, but potentially only during
translation of the protein when partially unfolded. Regardless of
the exact reason for this, these results demonstrate residues in and
around the 310-helix are involved in the binding of heme to IsdX1.
Figure 2. Superimposition of apo-IsdX1 and holo-IsdX1. (A) Ribbon representation of superimposition of apo-IsdX1 (pink) and holo-IsdX
(grey). (B) Heme-binding pocket with stick representation of heme (carbon, blue and Fe, orange sphere), apo-IsdX1 residues (carbon, pink) and holo-
IsdX1 residues (carbon, grey), and sulfur (yellow), nitrogen (blue) and oxygen (red). Arg-54 in the holo structure had two conformations and the
alternate conformation has cyan carbon atoms.
doi:10.1371/journal.ppat.1002559.g002
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In an attempt to provide a more quantitative assessment of the
importance of each residue in the 310-helix to the stabilization of
bound heme, we measured the rates of heme dissociation from
wild-type and mutant IsdX1 proteins. Each protein was purified
from E. coli as described in the Materials and Methods,
reconstituted with hemin, and holo-protein purified away from
unbound hemin by gel filtration chromatography. The rate of
heme dissociation was then assessed by mixing holo-IsdX1
preparations with excess H64Y/V68Y apo-myoglobin (Mb), a
mutant globin with a high heme affinity (Kd,10
212 M) and very
low rate of heme dissociation [30,48,49]. The dissociation rate
constant of heme loss from IsdX1 can be determined by measuring
the spectral changes that occur with time as released heme is
scavenged passively by the apo-Mb reagent.
As observed in Figure 5, IsdX1 containing mutations in Ser-53,
Arg-54, and Met-55 all lose heme significantly faster than wild-
type IsdX1, with S53A showing rates of heme loss that were
greater than 400 times faster than the wild-type IsdX1 (see Table 2
for rates). Interestingly, S52A showed comparable rates of heme
dissociation to that of wild-type, despite its apparent poor heme
binding ability at equilibrium (Figure 4D). The best explanation
for this is that while its rate of heme loss may be unaffected, its rate
of heme association in the absence of hemoglobin may be poor.
Taken together, the data are consistent with Ser-53 and Arg-54 of
the 310-helix playing a substantial role in stabilizing the bound
heme in IsdX1.
The role of the 310-helix in hemoglobin association
The position of 52-SSRM-55 extending over the heme-binding
site implies these residues may also be involved in the direct
interaction with hemoglobin. To test this hypothesis, the
association of each mutant with holo-hemoglobin was investigated
by surface plasmon resonance spectroscopy. Apo forms of wild-
type or mutant IsdX1 were infused over holo-hemoglobin
covalently coupled to a carboxy-methyl chip and the kinetics of
binding recorded by quantifying the change in response units
(RUs) with time. Whereas similar responses were observed for
wild-type, S52A, and M55A IsdX1, a significantly lower response
was observed when S53A or R54A were infused over holo-
hemoglobin (Figure 6, compare panels A, B, E to panels C, D).
Indeed, estimations of the dissociation constants (KD – Figure 6
legend) from the association and dissociation phases of the
response curves indicates that the S53A and R54A mutants, when
compared to wild-type IsdX1, display an approximately 10 and
386-fold increase, respectively, in KD, signifying a lower affinity for
hemoglobin. There was no interaction of the wild-type or mutant
IsdX1 proteins with apo-hemoglobin, which infers binding is
dependent on a heme-bound conformation of hemoglobin or is
facilitated by interactions with the solvent exposed heme
propionates in holo-hemoglobin (Figure 6F). These results indicate
Ser-53 and Arg-54 are important in the interaction of the IsdX1
hemophore with holo-hemoglobin and collectively suggest the
processes of heme binding and hemoglobin association in NEATs
are coupled for some residues but not others.
The role of the 310-helix in hemophore biology
IsdX1 and IsdX2 promote the growth of B. anthracis on
hemoglobin as the sole source of iron [26]. To determine the
functional contribution of the 52-SSRM-55 helix towards heme
scavenging activity, we tested the ability of wild-type and mutant
proteins to rescue a hemophore-dependent growth defect of a B.
anthracis strain (DisdX1, DisdX2) lacking both hemophores grown in
iron-deficient media with or without hemoglobin. Although little
Figure 3. Alignment of the 310-helix and adjacent residues of NEAT proteins in Gram-positive bacteria. ClustalW was used to align the
amino acid sequences of the annotated NEAT proteins from the Gram-positive bacterial pathogens Bacillus anthracis, Bacillus cereus, Staphylococcus
aureus, Streptococcus pyogenes, Clostridium (botulinum and perfringens), and Listeria monocytogenes. A serine (Ser-53 in IsdX1) is conserved in all nine
NEAT domains from B. anthracis and in several NEAT domains from other Gram-positive bacteria. Although an arginine occupies position 54 in IsdX1,
a methionine is commonly observed in related NEATs and may serve as a sixth axial ligand to the heme-iron, as described by Gaudin et al [62].
doi:10.1371/journal.ppat.1002559.g003
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wild-type IsdX1 to cultures with hemoglobin led to a 3 to 8-fold
increase in growth (Figure 7, compare 7 to 8, from 4 to 8 hrs). This
enhancement of growth is not due to heme or iron contamination
of the protein preparation since only a marginal increase in growth
was observed in the absence of hemoglobin (Figure 7, compare 8 to
1,2). Interestingly, whereas DisdX1, DisdX2 B. anthracis supple-
mented with S52A or M55A IsdX1 provided intermediate growth
(Figure 7, compare 9,12 to 3,6 at 8 hrs), the level of replication in the
S53A and R54A IsdX1 supplemented cultures was similar to the
S53A/R54A-only controls, suggesting these proteins are unable to
rescue a DisdX1, DisdX2-dependent growth defect on hemoglobin
as the sole iron source (Figure 7, compare 10,11 to 4,5 at 8 hrs).
Taken together, these results indicate Ser-53 and Arg-54-mediated
association of IsdX1 with hemoglobin is important for heme
scavenging in iron-limiting environments and provides the first
experimental demonstration of the biologic function of this
dynamic region in NEAT proteins in growing cells.
Figure 4. Functional role of the 310-helix and adjacent residues: heme binding. (A) Ser-52, Ser-53, Arg-54, and Met-55 of IsdX1, designated
SSRM, were each substituted to alanine and recombinant protein purified from E. coli as described in the Experimental Procedures. The absorbance
properties immediately after purification from E. coli of wild-type (black) and SSRM (grey) IsdX1 were analyzed from 260–560 nm. (B) Recombinant
IsdX1 was treated with low pH to remove co-purifying heme and the absorbance (250–500 nm) compared to the same preparation that was not acid
treated. (C, D) Wild-type IsdX1, IsdX1-SSRM, or IsdX1 harboring mutations in Ser-52, Ser-53, Arg-54, or Met-55 were purified from E. coli and the heme
content assessed by determining the ratio of the heme (399 nm) to protein (280 nm) absorbance (referred to as ‘‘bound heme’’). In (C), the relative
amount of associated heme is recorded following the purification of each IsdX1 variant from E. coli. In (D), all endogenous heme was removed from
the preparations as described in (B) and apo-proteins incubated with 5 mM heme for 10 minutes at 25uC, followed by absorbance measurements. The
absorbance value of a heme-only control (5 mM) was subtracted from all IsdX1 plus heme reaction readings. The values in (C) and (D) represent the
mean and standard deviation of three independent experiments. The asterisk (*) means the differences were significant (p,0.05).
doi:10.1371/journal.ppat.1002559.g004
Mechanism of a NEAT Hemophore
PLoS Pathogens | www.plospathogens.org 7 March 2012 | Volume 8 | Issue 3 | e1002559Discussion
Here, we report (i) the crystal structure of the apo and holo
forms of a Gram-positive hemophore, (ii) the structure of a non-
staphylococcal NEAT protein, (iii) that residues in and adjacent to
the 310-helix contribute to the binding of the heme-iron in this
hemophore, (iv) that the processes of heme binding and
hemoglobin association can be delineated, and (v) that both
optimal heme and hemoglobin binding are necessary for full
hemophore activity for growing bacilli. Thus, these studies extend
our knowledge of the molecular mechanism of NEAT protein
function and provide evidence that abolishing a functional
interface between the NEAT domain and hemoglobin can slow
bacterial growth in iron-limiting environments.
Research into bacteria hemophores is a growing field, and
several hemophores have been discovered [10,16,50,51]. The
most well-documented secreted hemophore is that of HasA from
the Gram-negative pathogen S. marscescens [52]. Although
functionally similar, it is likely that IsdX1 and HasA resulted
from convergent evolution, as there is little structural similarity
between the two proteins. Whereas HasA obtains heme from
hemoglobin through a passive mechanism that does not seem to
require a physical interaction, IsdX1 binds hemoglobin directly,
an event that likely facilitates heme transfer [15,24,26]. Both
proteins transfer the bound heme to their cognate cell surface
receptors (IsdC for IsdX1 and HasR for HasA) through direct
engagement. However, the IsdX1-IsdC interaction is dependent
on the hemophore being heme loaded and is transient [30]. This
Figure 5. Heme dissociation kinetics for wild-type and mutant IsdX1. Wild-type or mutant (S52A, S53A, R54A, or M55A) IsdX1 were purified
from E. coli and endogenous heme removed as described in the Materials and Methods. Proteins were re-constituted with heme, excess heme
removed by gel filtration chromatography, and holo proteins (1 mM) mixed with H64Y/V68F apo-Mb (26 mM) at 25uC in PBS, pH 7.4. Time courses for
hemin dissociation the IsdX1 variants were determined by measuring the difference between in the increase in absorbance at 419 nm (peak for holo
H64Y/V68F holo-Mb) and the decrease in absorbance at 380 nm (strong absorbance by holo-IsdX1).
doi:10.1371/journal.ppat.1002559.g005
Table 2. Rate constants for heme dissociation from IsdX1
variants.
IsdX1 variant Rata constant (min
21) Halftime (min)
a
Wild-type k=0.0034 190
S52A k=0.0034 190
S53A
b k1=1.4 (70%), k2=0.03 (30%) 1
R54A k1=0.042 (30%), k2=0.0035 (70%) 110
M55A k1=0.077 (20%), k2=0.01 (80%) 47
aThe halftime is defined as the amount of minutes for one-half of the heme to
dissociate from IsdX1.
bFor S53A and R54A, the dissociation curves are best described by two phases,
each with a single rate constant. The percentages indicate the proportion of the
total population giving that particular rate.
doi:10.1371/journal.ppat.1002559.t002
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and holo forms of HasA bind with similar affinities and to the same
site on HasR [15,53]. More recently, several secreted hemophores
have been reported. HmuY, from P. gingivalis, binds heme and may
deliver its heme to the surface receptor HmuR [54,55]. Also in P.
gingivalis, the recently described HusA is a heme-binding protein
that is needed for growth under conditions of heme limitation [12].
A putative secreted hemophore from Mycobacterium tuberculosis has
been characterized with a proposed heme-binding site consisting
of one Tyr and two His, which has a similar heme-binding
structural motif to that of HasA [56]. However, the overall fold of
the Mtb hemophore is structurally diverse in comparison with
both HasA and IsdX1 folds, and it was postulated that the Mtb
hemophore may also be a product of convergent evolution [56].
Recent work has shed new insights into how Gram-positive
bacteria acquire heme from mammalian hosts [57,58]. The central
structural unit is the NEAT domain, a protein module that
mediates heme acquisition and import at the bacterial surface
[26,29,31,41,57–61]. If NEAT proteins are to be targets for the
development of anti-infectives, the molecular determinants of their
mechanism of action need to be defined. In this context, the study
of IsdX1 is particularly appropriate because this protein contains
the only known NEAT domain that contains all the activities
associated with hemophore activity (heme and hemoglobin
association, heme extraction from hemoglobin, and heme transfer
to receptors) [26]. Thus, the study of IsdX1 allows for insights into
the relationship between heme coordination, hemoglobin binding,
and heme extraction from mammalian globins.
To gain insights into these activities, we solved the 3-
dimensional structure of apo and holo IsdX1. The overall
structure is similar to the structures of the staphylococcal NEAT
domains of IsdH (NEAT 1/3) [40,44], IsdA [41], IsdC [42,43],
Figure 6. Functional role of the 310-helix and adjacent residues: hemoglobin association. Wild-type (A), S52A (B), S53A (C), R54A (D), or
M55A (E) IsdX1 were infused at 100, 200, 300, 350, or 500 nM over holo or apo-hemoglobin (wild-type only, panel F) coupled to a CM5 chip and
response units recorded over 800 seconds. The dissociation constants (in nanomolar) were as follows: wild-type=15.060.07, S52A=14.060.17,
S53A=139.062.5, R54A=5, 50061, 800, and M55A=18.060.4. Due to the weak response of R54A, the KD was calculated from response curves using
concentrations approximately 100 times that injected for the wild-type protein. All other dissociation constants represent the mean and standard
deviation of three independent measurements for the injection of 300 nM (final concentration) IsdX1 (x
2,than 1.0). Hb=hemoglobin.
doi:10.1371/journal.ppat.1002559.g006
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immunoglobulin-like fold arranged into eight b-sheets, (ii) a small
4–5 residue 310-helix extending over the heme-binding pocket,
and (iii) two anti-parallel b-sheets that house a conserved tyrosine
(Tyr-136 in IsdX1) which coordinates the heme-iron (Figure S2A).
However, surface charge calculations indicate a charge distribu-
tion on IsdX1 quite distinct from the other NEAT domains,
including a net positively charged region near the 310-helix of the
heme pocket (Figure S1). It is not known if this difference relates to
the fact that IsdX1 acts extracellularly after secretion, as opposed
to the staphylococcal NEAT proteins that are covalently anchored
to the cell wall. Of note is the finding that the staphylococcal
homolog of the putative receptor for IsdX1 (IsdC) contains overall
anionic character in this region, a feature which leads one to
postulate that opposing charges may partially dictate the
association between these two proteins upon heme transfer.
The structures of apo-IsdX1 and holo-IsdX1 are highly similar
with RMSD of 0.51 A ˚. However, superimposition of both apo and
holo structures highlight subtle residue sidechain conformational
differences surrounding the heme binding site. This finding
suggests residues in the 310-helix may partially stabilize the
heme-free form (discussed below), a requirement of this hemo-
phore immediately after secretion into host tissues. To accommo-
date the heme molecule, there is a shift in the residue sidechains of
Arg-54 (2.5–2.8 A ˚), Arg-57 (7.3 A ˚), Tyr-58 (2.1 A ˚), Tyr-136
(1.6 A ˚) and Tyr-140 (2.6 A ˚), away from the center of the heme
binding pocket. Additionally, there is observable electron density
for two side chain conformations for Met-55 within the apo
structure, where one conformation is pointing toward the center of
the heme binding pocket and the other away into the interior of
IsdX1. Met-55 in the holo structure has its side chain pointing into
the interior of the protein and makes hydrophobic contacts with
the heme pyrrole ring. In contrast, there is no conformational
change observed for either Ser-52 or Ser-53 between the holo and
apo structures.
It is interesting to note that within the holo-IsdX1 structure,
crystal lattice packing interactions occur through a heme-mediated
protein interface between two holo-IsdX1 molecules from adjacent
asymmetric units (Figure S5A, B). Two heme molecules from
adjacent subunits planar stack upon one another (inter-iron
distance of 5.7 A ˚) and the crystallographic interface is further
stabilized by two hydrogen-bonds; one from the NH2 group of
Arg-54 from Chain A to the most solvent exposed heme
propionate from Chain B and the second from the NH1 group
from Arg-57 from Chain B to the hydroxyl group of Asn-135 on
the adjacent molecule. The apo-IsdX1 structure also has a similar
protein interface near the vicinity of the heme-binding sites of
adjacent monomers; however due to the lack of heme, there are
more protein interactions between loop regions surrounding the
active site (Figure S5A,B). We believe the heme stacking
interaction, while caused by crystal packing, may reflect how
IsdX1 transfers heme to downstream NEAT domain proteins such
as B. anthracis IsdC. Indeed, Grigg et al (published during review of
this paper) proposed that inter-NEAT domain interactions
between S. aureus IsdB and IsdA may occur along the heme-
mediated crystal symmetry interface based on in silico docking
predictions [63]. Moreover, an NMR analysis by Villareal et al
(also published during review) of the interaction between S. aureus
IsdC and IsdA demonstrated that in the IsdC-IsdA complex the
proteins are pseudosymmetrically arranged through a 180u
rotation that is coplanar with the heme plane, which is identical
to the symmetry relationship between IsdX1 monomers from
adjacent asymmetric units [64]. Thus, our data also lend
experimental support to these models.
Figure 7. Functional role of the 310-helix and adjacent residues: hemophore and NEAT-domain biology. Purified wild-type or mutant
IsdX1 were added to a final concentration of 1 mM to hemophore-deficient (DisdX1, DisdX2) B. anthracis Sterne 34F2 grown in iron-chelated RPMI with
or without hemoglobin (10 mM) and the OD600 recorded at 2, 4, 6, and 8 hours. The results represent the mean and standard deviation of three
independent experiments. The asterisk (*) means the differences were significant (p,0.05). Hb=hemoglobin.
doi:10.1371/journal.ppat.1002559.g007
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IsdX1, several interesting properties can be gleaned from this
study. First, amino acids in this region contribute to the
stabilization of heme, as demonstrated by the fact that the
substitution of Ser-52, Ser-53, and Met-55 to alanine abrogated
the ability of IsdX1 to attain heme from E. coli lysates as well as
bind pure hemin when incubated with the apo protein. Mutation
of Arg-54 led to significantly higher amounts of heme co-purifying
with IsdX1. However, removal of this heme and assessment of
hemin binding yielded a protein unable to subsequently coordinate
heme. We cannot definitively explain this result, other than to
propose that it is possible that while being synthesized in E. coli, the
partially unfolded IsdX1 binds the heme and then folds thereby
enclosing upon the iron-porphyrin. Upon heme removal, the
resulting apo protein, potentially highly ordered, now becomes
restricted and does not allow heme to access the binding pocket.
Interestingly, this was not observed in an IsdA variant harboring
an alanine substitution in the equivalent position (His-83) [41]. It
was proposed this position in IsdA and IsdC (Ile-48) sterically
hindered access to the sixth coordination position of the heme-
iron. Indeed, cyanide and azide, two ligands often used to probe
accessibility to the sixth position, did not bind IsdA or IsdC
[42,65]. The ability of the E. coli form of R54A to associate with
more heme while expressed in E. coli may provide experimental
support for this hypothesis, with Arg-54 sterically blocking access
to Try-136 in the wild-type protein.
Second, mutation of this region decreases hemoglobin associa-
tion; however, differential effects are observed. Substitution of Ser-
53 and Arg-54 with alanine significantly reduced binding to
hemoglobin, with R54A yieldingthe largest effect (greater than 300-
fold). However, mutation of Ser-52 and Met-55, the two residues
flanking Ser-53 and Met-54, produced hemoglobin-binding affin-
ities similar to the wild-type protein. These findings support a model
bywhichArg-54,beingratherforwardinitslocationovertheheme-
binding site, provides initial contact with hemoglobin, perhaps
stabilizing the initial interaction. The engagement of Arg-54 with
hemoglobin may ‘‘peel’’ the side chain of this residue away from the
heme-binding site, thus removing the steric block observed for
residues in this position for other NEAT proteins. Further support
for this hypothesis is that the hemoglobin-binding NEAT domain,
IsdB-N2, has a Met in the same position as Arg-54, and the crystal
structure of IsdB showed an alternate conformation of Met
coordinated with heme-iron, whereby the authors suggest that this
Met might be involved in heme transfer. If alternate conformations
of Arg-54 are sampled, one conformation has the NH1 group of
Arg-54 coordinated to heme-iron similar to IsdB (Figure S2, lower
panel). Thus, Arg-54, by virtue of its unique orientation in the
heme-binding pocket, may mediate several processes related to
heme extraction from hemoglobin. In essence, this residue may
function as a ‘‘molecular placeholder’’ by initially binding the heme
during the first step of transfer. In support of this hypothesis, there is
evidence that arginine can assist in heme binding in other systems
[66]. Ser-53, whose side chain is directed towards the heme-binding
site, would next be free to hydrogen bond with a heme propionate,
thereby strengthening the IsdX1-hemoglobin interaction.
Once Ser-53 engages the heme, Tyr-136 of IsdX1, from the
opposite side of the heme, can now displace hemoglobin’s His-iron
coordination to become the fifth axial ligand of IsdX1, with Tyr-
140 providing additional strength for this coordination by H-
bonding to the phenolate of Tyr-136. In addition to Tyr-136, the
heme is also secured in the binding pocket by Ser-53 and Arg-54,
since these residues show the highest rates of heme loss when
mutated. Ser-52, whose mutation does not lead to greater heme
dissociation, may also assist in drawing the heme into the heme-
binding pocket but once the heme is in, does not contribute much
to its stabilization. This hypothesis aligns well with the observation
that the side chain of this residue sticks out into the solvent while
the side chain of its neighbor, Ser-53, points into the heme-binding
pocket.
During review of our manuscript, Kumar et al described the
first ever co-crystal of a NEAT protein (the first NEAT domain of
IsdH from S. aureus) in complex with the alpha-chain of
hemoglobin [67]. The structure reveals several stabilizing contacts
between the 310-helix of IsdH and hemoglobin, thereby confirm-
ing our predictions for the role of this helix in direct association
with hemoglobin and heme scavenging. Perhaps most important is
a hydrogen bond between a serine in IsdH NEAT 1 (Ser-130) with
Lys-11 on hemoglobin. This serine is just 5 residues downstream of
what would be the position of Ser-53 in IsdX1, leading us to
speculate that the lack of functional interaction with hemoglobin
observed upon mutation of this residue is because a key hydrogen
bond is severed in the IsdX1-Hb interaction.
Whether or not the function of the 310-helix is confined only to
heme acquisition from hemoglobin remains to be determined. For
example, Grigg et al found the conserved coordinating tyrosine in
the first NEAT domain of IsdA (the equivalent of Tyr-136 in
IsdX1), and not residues in the 310-helix, played a role in NEAT to
NEAT heme transfer [63]. In contrast, Villareal et al found that
mutation of a single 310-helix residue in S. aureus IsdA did affect
NEAT to NEAT heme transfer; however, this mutation was
coupled to another mutation elsewhere in the protein that was also
believed to mediate NEAT-NEAT binding [64]. Thus, more work
is required to determine if the 310-helix also functions in
downstream heme transfer processes.
Although this model of hemoglobin and heme binding is
consistent with available data, we cannot rule out that there are
additional residues outside of the 310-helix that participate in this
process. Indeed, as demonstrated by Pilpa et al [46] for one of the
staphylococcal hemoglobin receptors (NEAT 1 of IsdH) [68,69],
amino acids distal to this position (on the b3–b4 loop), also seem to
be important for hemoglobin association. However, NEAT 1 of
IsdH does not bind heme, and instead requires a third NEAT
domain (NEAT 3), to acquire and stably bind the heme from the
IsdH NEAT 1-hemoglobin complex. Thus, the data suggests
residues in and around the 310-helix in IsdX1 evolved to bind both
heme and hemoglobin, as well as those that are not interdepen-
dent, in order to provide several functionalities (hemoglobin
binding coupled to heme extraction) within a single NEAT
domain.
Finally, the exogenous addition of recombinant IsdX1 to culture
restored the growth of a hemophore-deficient strain of B. anthracis
on hemoglobin, suggesting all the information necessary for
hemophore activity is contained within its amino acid sequence.
The partial restoration of growth observed by S52A and M55A
may be due to the ability of these mutants to still bind heme, albeit
poorly, after association with hemoglobin. Although S53A and
R54A bind heme at similar levels as S52A and M55A, it would
seem their much lower affinity for hemoglobin precludes them
from acquiring any heme in this assay (or alternatively, does not
promote the release of enough heme from hemoglobin), meaning
no or little free heme is available for transfer (or sequestration) at
the bacterial surface. Because mutation of Ser-52, Ser-53, Arg-54,
and Met-55 results in poor heme-binding activity, it is difficult to
biochemically determine the exact role of these residues in the
ability of IsdX1 to extract heme from hemoglobin. However, it is
clear from the SPR and growth studies that mutations that effect
the association with hemoglobin significantly compromises
hemophore activity. Performing an identical experiment with a
Mechanism of a NEAT Hemophore
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phenotype to evaluate these mutants for function (data not shown),
likely because IsdX1 and IsdX2 are functionally redundant [26].
Taken as a whole, these experiments highlight the biological role
of the 310-helix in NEAT protein function and hemophore biology
and provide direct evidence that the mechanistic extraction and
binding of heme from hemoglobin are important for B. anthracis
replication in low-iron environments.
Although attempts to develop a universal inhibitor of heme
uptake is likely to be challenging, the seemingly conserved
functional properties shared by distinct NEAT domains does offer
the prospect of targeting these processes in select Gram-positive
bacteria. As we make advances in our understanding of NEAT
mechanism of action, the elucidation of additional structures, an
understanding of side chain chemistry in transfer reactions, and
the identification of factors that drive ligand binding specificity,
will all be required for the creation of novel anti-infectives that
prevent iron-porphyrin uptake in these pathogenic bacteria.
Materials and Methods
Bacterial strains, reagents, and mutagenesis
DNA encoding for amino acids 26–146 of IsdX1 were amplified
from the genome of B. anthracis strain Sterne 34F2 using PCR and
primers containing EcoRI and BamHI restriction sites [70].
Amplified DNA was digested, ligated into pGEX2TK, and
pGEX-IsdX1 transformed into E. coli BL21 for the expression of
IsdX1 as a glutathione-S-transferase (GST) fusion protein as
described [26,29]. For the purification of IsdX1 used to generate
the holo-protein crystals, DNA encoding residues 27–152 was
cloned into pET28a (Novagen) encoding a fusion protein of IsdX1
with a His(6)-tag using NheI and NotI restriction enzyme sites. The
26–146 (apo) and 27–152 (holo) protein constructs were chosen
because they yielded crystals that diffracted with the highest
resolution. Site-directed mutagenesis of IsdX1 was performed on
the 26–146 IsdX1 construct using QuikChange (Stratagene, Santa
Clara, CA) according to the manufacturer’s instructions. After
DpnI digestion of reaction mixtures, DNA was transformed into E.
coli BL21 and the resultant plasmid clones sequenced to confirm
the presence of the mutation [71,72]. All E. coli strains were grown
in Luria-broth (LB) supplemented with 50 mg/mL ampicillin
(Fisher Scientific, Waltham, MA) except for the pET28a construct
that was supplemented with 30 mg/mL kanamycin (Fisher).
Purification of proteins for activity studies
Wild-type and mutant IsdX1 proteins were purified by GST-
affinity chromatography as previously described [26,29]. Briefly,
50-mL of overnight cultures of E. coli BL21 containing wild-type or
mutant pgst-isdX1 were inoculated into 2-L of LB with ampicillin
and rotated at 250 rpm at 37uC. After 2 hours, isopropyl- b-D-
thiogalactopyranoside (IPTG - 1.5 mM) was added and cultures
grown for an additional 2 hours. Bacteria were centrifuged at
6,0006g for 8 min, resuspended in phosphate buffered saline (PBS
- 137 mM NaCl, 2.7 mM KCl, 10 mM sodium phosphate dibasic,
2 mM potassium phosphate monobasic, pH 7.4), and cells lysed
by French press. The supernatant was obtained by centrifugation
at 30,0006g for 15 min and filtered through a 0.45-mm pore-size
cellulose filter. Lysates were next applied to 1-mL of glutathione-
sepharose (GE Healthcare, Piscataway, NJ), washed with 40-mL of
PBS, and bound protein incubated with thrombin (100 units, GE
Healthcare) for 3 hours at 25uC. GST-free IsdX1 preparations
were next incubated with 200-mL of aminobenzamidine sepharose
(Sigma, St. Louis, MO) to remove thrombin. To remove
endogenous heme, preparations were treated with HCl (final pH
of 2.0) and methyl ethyl ketone was added to separate heme
(organic layer) from IsdX1 (aqueous layer) as described [73].
Protein concentrations were either determined by UV/vis
spectroscopy, the bicinchoninic acid method (Pierce, Rockford,
IL), or by SDS-PAGE [74]. All protein preparations were stored at
220uC.
Purification of proteins for crystallography
apo-IsdX1 - To obtain an IsdX1 preparation for crystal seeding,
IsdX1 was expressed and bound to glutathione-sepharose as
described above [26,29]. Bound protein was then cleaved from the
column with Factor-XA (10 units, Amersham Biosciences) in
1 mM CaCl2, 100 mM NaCl, 50 mM Tris pH 7.9 for 16 hours.
Heme was removed as described above and IsdX1 further purified
by cation exchange chromatography using a Mono S column (GE
Healthcare) and gel filtration chromatography using a Superdex
200 column (GE Healthcare). Selenomethionine-substituted pro-
tein was produced by inhibiting methionine biosynthesis and
purified as above.
Holo-IsdX1 - IsdX1 was transformed into BL21-Gold (DE3)
cells and grown at 37uC in LB medium containing 30 mg/mL
kanamycin. Protein expression was induced when cells reached
OD600 nm of 0.8 by the addition of 1 mM IPTG and cells
harvested after 4 hours by centrifugation at 5, 100 rpm for
20 minutes, followed by resuspension in 50 mM Tris, pH 7.4, and
350 mM NaCl. Cells were next lysed by sonication after addition
of egg hen lysozyme (5 mg, Sigma) with phenylmethylsulfonyl
fluoride (40 mM, Sigma) and the cell lysate centrifuged at 14,
000 rpm for 20 minutes. After addition of 400 mL Proteoblock
protease inhibitor cocktail (Fermentas), the supernatant was
loaded onto a Ni
2+-charged HisTrap column (GE Healthcare)
and eluted with a linear imidazole gradient (between 100–
250 mM imidazole). Fractions containing IsdX1 were identified
by SDS-PAGE, pooled and concentrated using a Centricon
centrifugal concentrator (Millipore). Further purification of IsdX1
was achieved by running the protein over an S75 gel filtration
column (GE Healthcare) equilibrated with 50 mM Tris pH 7.4,
150 mM NaCl, which yielded nearly 100% homogeneous protein.
Cleavage of the His(6)-tag was conducted in cleavage buffer
(50 mM Tris pH 7.4, 150 mM NaCl, 10 mM CaCl2) by adding
1 mL of thrombin-agarose suspension (Sigma) to the protein,
followed by removal of thrombin-agarose on a glass frit. IsdX1 was
then run over an S75 gel filtration column equilibrated with
50 mM Tris pH 7.4, 150 mM NaCl to separate IsdX1 from the
His(6)-tag.
Crystallization and structure determination
apo-IsdX1 - Purified IsdX1 in buffer A [10 mM MES pH 6.6,
200 mM NaCl] crystallized at room temperature using the
hanging drop vapor diffusion method and a reservoir solution of
0.1 M citric acid pH 3.5 and 2 M NaCl. Crystals were frozen in
N2 (l) following cryoprotection with the reservoir solution
containing 16% glycerol. Data were collected to 1.8 A ˚ at the
Structural Biology Center beamline 19-BM at the Advanced
Photon Source (APS), Argonne National Laboratory (ANL), and
processed using HKL2000 [75]. SeMet-IsdX1 crystallized with a
reservoir solution of 0.1 M citric acid pH 3.5 and 3.3 M NaCl and
was frozen as above. Data were collected to 2.1 A ˚ at the Life
Sciences Collaborative Access Team (LS-CAT) beamline 21-ID-D
at the APS, and processed with XDS and scaled using SCALA
(Table 1) [76]. The structure was determined by the single-
wavelength anomalous dispersion method using the anomalous
scattering from two selenium atoms in the asymmetric unit
cell with the program PHENIX [77]. The model was built
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refined with PHENIX.
Holo-IsdX1 - Approximately 4 mg of heme were dissolved in
0.4 mL of ice cold 0.1 M NaOH and vortexed periodically. After
30 minutes, 0.4 mL of 1 M Tris, pH 7.4 was added to the
solution. The solution was subsequently centrifuged for 10 minutes
at 4uC at 13,000 rpm. The heme solution was then diluted with
50 mM Tris, pH 7.4, 150 mM NaCl and centrifuged again at 5,
100 rpm to remove any heme aggregates. Final concentrations
were determined using e385=58.44 mM
21 cm
21. Heme solutions
were used within 12 hours.
Holo-protein was reconstituted by slowly adding 1.5-fold excess
heme to IsdX1 preparations in small increments. The UV/vis
absorption spectrum was recorded after each addition of heme and
saturation with heme was evident by the shift in the Soret
maximum from 399 nm to a shorter wavelength. After 1-hour
incubation at room temperature, excess heme was removed using
an S200 gel filtration column (GE Healthcare) and the protein
collected in 1-mL fractions. The UV/vis absorbance spectrum for
each fraction was recorded and those with a Soret peak maximum
at 399 nm and Abs399/Abs280 ratios greater than 3 were pooled.
Protein concentrations were measured using the modified Lowry
assay (Pierce, Rockford, IL). The extinction coefficient for the
Soret peak at 399 nm was determined to be equal to
100 mM
21 cm
21 by the pyridine hemochrome assay and used
for hemoprotein concentration determination [79]. Holo-IsdX1
was concentrated to 100 mg/mL in 50 mM Tris pH 7.4, 150 mM
NaCl for crystallization trials.
Crystals of holo-IsdX1 were grown by the hanging drop, vapor
diffusion method against a reservoir containing 0.1 M SPG buffer,
pH 9.0and 25%polyethylene glycol 1500 with crystallizationdrops
containing 0.25 mL of protein to 0.25 mL of reservoir solution.
Crystal growth was observed within 24 hours. The crystal was
passed through a 1:1 v/v solution containing the reservoir solution
and glycerol for cryoprotection and the crystals harvested under
cryoconditions. The diffraction data was collected at 77 K on
beamline 9-2 at Stanford Synchrotron Radiation Lightsource. Two
data sets were collected, a native set at 1.0 A ˚ and a Fe-SAD set at
theiron absorption edge(1.738 A ˚).Images were indexed, integrated
and reduced using the HKL2000 suite resulting in a 99.1%
complete dataset to 2.15 A ˚ resolution for the native set and a 98.2%
complete dataset to 2.3 A ˚ resolution for the Fe-SAD set. The unit
cell dimensions are equal to 65.1 A ˚665.1 A ˚674.4 A ˚ in the space
group P43 with two molecules of holo-IsdX1 per asymmetric unit
(Table 1). The initial phases were calculated using Phaser [80] with
apo-IsdX1 as the search model and the resulting electron density
map was subjected to automated and manual model building
procedures through a combination of PHENIX.autobuild [77],
PHENIX.refine [77] and Coot [78]. Subsequently, two heme-iron
sites per asymmetric unit were detected from the anomalous iron
signal using SHELXC/D/E [81]. This additional phase informa-
tion was combined with the molecular replacement model phases
through SIGMAA and DM in CCP4i [82], which improved the
resulting electron density map for a final round of refinement.
Programs from the CCP4 package [82] as well as Phenix [77],
Pymol [83], and Coot[84] were used to analyze the stereochemistry
and geometry of the models and were found to be acceptable. Data
collection and refinement statistics are presented in Table 1.
Heme-binding analysis
Apo forms of wild-type or mutant recombinant IsdX1 (5 mM)
were incubated with hemin chloride (5 mM – Sigma) in PBS,
pH 7.4 for 10 minutes at 25uC. Reactions were then subjected to a
wavelength scan from 250–560 nm using a DU800 spectropho-
tometer (Beckman-Coulter, London, UK) [29]. The relative
amount of bound heme was calculated as: (T399 nm2C399 nm)/
T280 nm, where T399 nm=the absorbance maximum at 399 nm for
samples containing IsdX1 with heme, C399 nm=the absorbance
maximum at 399 nm for samples containing heme only, and
T280 nm=the absorbance maximum at 280 nm for samples
containing IsdX1 with heme. To measure the rates of heme
dissociation, wild-type or mutant IsdX1 were re-constituted with
heme, excess heme removed by gel filtration chromatography, and
holo proteins (1 mM) mixed with apo-Mb (26 mM) at 25uC in PBS,
pH 7.4. Dissociation rates are determined by measuring the
increase in absorbance at 419 nm (apo-Mb) versus a reference,
control wavelength (380 nm).
Hemoglobin-binding analysis
The interaction of wild-type and mutant IsdX1 proteins with
hemoglobin was measured using a BIAcore 3000 biosensor
(Amersham Biosciences, Piscataway, NJ) [30]. Briefly, 100 mLo f
holo- or apo-hemoglobin (Sigma-H2500, 10 mM in 50 mM Tris-
HCl, pH 7.0) was covalently coupled to a CM5 sensor chip at 25uC
to a density of 4000 response units (RUs) using amine chemistry as
previously described [85,86]. Wild-type or mutant IsdX1 proteins
(100, 200, 300, 350, or 500 nM) in HBS-N (0.01 M HEPES,
0.15 M NaCl, pH 7.4) were injected at 20 mL/min for 300 s at
25uC and response curves followed for a total of 800 seconds. A
parallel injection of IsdX1 over a blank CM5 surface (no
hemoglobin) was used to control for non-specific binding. Injections
at each concentration were performed in triplicate, and the data
from the 300 nM injection used to calculate the dissociation
constants, which were determined using BIAevaluation 4.1 software
(Amersham Biosciences) after fitting the data to a 1:1 Langmuir
binding model with dR/dt=kaC(Rmax2R)2kdR, where R is the SPR
signal (in response units), ka is the association rate constant (in
M
21 s
21), kd is the dissociation rate constant (in s
21), C is the
concentration of holo-IsdX1 (in M), Rmax is the maximum holo-
IsdX1 binding capacity (in response units), and dR/dt is the rate of
change of the SPR signal [87].
B. anthracis growth experiments
Purified IsdX1 (wild-type or mutant proteins) were treated with
HCl and methyl ethyl ketone to remove any endogenous heme
[88]. Preparations were then dialyzed against 2-L of PBS (pH 7.4)
and treated with 100 mg/mL Chelex-100 (Sigma) to remove any
contaminating free iron. B. anthracis Sterne strain (34F2) harboring
deletions in both isdX1 and isdX2 [26] were subcultured into 3-mL
of LB plus kanamycin at 30uC. After 12-hours, cells were washed
26with PBS and 5-mL of washed, normalized cells inoculated into
500-mL of RPMI (iron chelated by treatment with 100 mg/mL
Chelex-100 for 12 hours) with or without hemoglobin (10 mM) in
a 48-well Costar tissue-culture plate. Wild-type or mutant proteins
(1 mM) were next added to each well and OD600 recorded at 2, 4,
6, and 8 hours at 37uC using a Tecan 200 Pro microplater reader.
The results represent the mean and standard deviation of three
independent experiments.
Circular Dichroism Spectroscopy
Circular dicroism spectra of apo forms of wild-type and mutant
IsdX1 were obtained using a JASCO-815 CD spectropolarimeter
at 25uC [89,90]. Protein samples were resuspended in PBS buffer,
pH 7.4 at a concentration of approximately 50 mM. Far-UV
spectra were recorded from 200–260 nm using a 1-mm path
length at a scanning speed of 50 nm/min, with a bandwidth of
2 nm. Raw spectra are shown and represent the average
accumulation of six scans.
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Supporting Information
Figure S1 Comparison of surface charge distribution of
IsdX1 to the S. aureus (Sa) NEAT domain structures.
Molecular surface representation with electrostatic potential as
shown from 270 eV (negative, red) to +70 eV (positive, blue).
Heme is represented by stick model and Fe as an orange sphere,
with carbon, oxygen and nitrogen atoms colored in purple, red
and blue, respectively. The PDB codes are Ba-IsdX1 (3SIK), Sa-
IsdH-N3 (2Z6F), Sa-IsdC (2O6P), Sa-IsdA (2ITF) and Sa-IsdB-N2
(3RTL).
(TIF)
Figure S2 Comparison of NEAT domain structures.
Upper panel, Comparison of the heme-binding pocket of the
IsdX1 NEAT domain to those of S. aureus (Sa) NEAT proteins.
Heme and residues in close proximity are represented by stick
model with heme carbon atoms in purple and Fe as an orange
sphere (all oxygen, nitrogen, and sulfur atoms colored red, blue,
and yellow, respectively). Lower panel, An alternative conforma-
tion of Arg-54 coordinated to heme-iron is shown.
(TIF)
Figure S3 Spectral properties of wild-type and mutant
IsdX1. Wild-type (black) or S52A, S53A, R54A, or M55A (grey)
IsdX1 were purified from E. coli and the absorbance properties
from 250–650 nm analyzed immediately after purification.
(TIF)
Figure S4 Far-UV CD analysis of wild-type and mutant
IsdX1. Spectra of apo forms of wild-type and mutant IsdX1
(50 mM) were obtained using a JASCO-815 CD spectropolarim-
eter at 25uC.[89,90] Raw spectra are shown and represent the
average accumulation of six scans.
(TIF)
Figure S5 Comparison of crystal packing of apo-IsdX1
and holo-IsdX1. (A) Crystal packing of apo-IsdX1. Ribbon
representation with two molecules in the asymmetry unit (blue
box), where b-strands and helices are colored pink and cyan,
respectively. The black line represents the non-crystallographic
symmetry between the two molecules where one observed protein-
interactions. Symmetry molecules are colored in light pink.
Tyr166 and Tyr170 in the heme-binding site are in stick
representation with carbon, nitrogen and oxygen atoms colored
white, blue and red respectively. The protein interface formed by
crystallographic symmetry occurs at the heme-binding site of two
molecules. (B) Crystal packing of holo-IsdX1. Ribbon represen-
tation with two molecules in the asymmetry unit (blue box), where
b-strands and helices are colored yellow and red, respectively. The
black line represents the non-crystallographic symmetry between
the two molecules, where in contrast to apo-IsdX1, one observes
no protein interface. Symmetry molecules are colored in light
yellow. Tyr166 and Tyr170 in the heme-binding site are in stick
representation with carbon, nitrogen and oxygen atoms colored
white, blue and red respectively. Heme is in stick representation
with carbon atoms in grey. The protein interface formed by
crystallographic symmetry occurs between two heme molecules
from crystallographic related molecules.
(TIF)
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